Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 4
2008 2
2009 2
2010 4
2011 3
2012 2
2013 4
2014 1
2016 3
2017 3
2018 5
2019 4
2020 5
2021 7
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results.
Daver NG, Vyas P, Kambhampati S, Al Malki MM, Larson RA, Asch AS, Mannis G, Chai-Ho W, Tanaka TN, Bradley TJ, Jeyakumar D, Wang ES, Sweet K, Kantarjian HM, Garcia-Manero G, Komrokji R, Xing G, Ramsingh G, Renard C, Zeidner JF, Sallman DA. Daver NG, et al. Among authors: xing g. J Clin Oncol. 2023 Nov 1;41(31):4893-4904. doi: 10.1200/JCO.22.02604. Epub 2023 Sep 13. J Clin Oncol. 2023. PMID: 37703506 Free PMC article. Clinical Trial.
Idelalisib immune-related toxicity is associated with improved treatment response.
Wagner-Johnston ND, Sharman J, Furman RR, Salles G, Brown JR, Robak T, Gu L, Xing G, Chan RJ, Rajakumaraswamy N, Gopal AK. Wagner-Johnston ND, et al. Among authors: xing g. Leuk Lymphoma. 2021 Dec;62(12):2915-2920. doi: 10.1080/10428194.2021.1948038. Epub 2021 Jul 28. Leuk Lymphoma. 2021. PMID: 34319205 Free PMC article.
Outcomes of patients with up to 6 years of follow-up from a phase 2 study of idelalisib for relapsed indolent lymphomas.
Wagner-Johnston ND, Schuster SJ, deVos S, Salles G, Jurczak WJ, Flowers CR, Viardot A, Flinn IW, Martin P, Xing G, Rajakumaraswamy N, Gopal AK. Wagner-Johnston ND, et al. Among authors: xing g. Leuk Lymphoma. 2021 May;62(5):1077-1087. doi: 10.1080/10428194.2020.1855344. Epub 2020 Dec 10. Leuk Lymphoma. 2021. PMID: 33300385 Clinical Trial.
A radio pulsar phase from SGR J1935+2154 provides clues to the magnetar FRB mechanism.
Zhu W, Xu H, Zhou D, Lin L, Wang B, Wang P, Zhang C, Niu J, Chen Y, Li C, Meng L, Lee K, Zhang B, Feng Y, Ge M, Göğüş E, Guan X, Han J, Jiang J, Jiang P, Kouveliotou C, Li D, Miao C, Miao X, Men Y, Niu C, Wang W, Wang Z, Xu J, Xu R, Xue M, Yang Y, Yu W, Yuan M, Yue Y, Zhang S, Zhang Y. Zhu W, et al. Among authors: guan x. Sci Adv. 2023 Jul 28;9(30):eadf6198. doi: 10.1126/sciadv.adf6198. Epub 2023 Jul 28. Sci Adv. 2023. PMID: 37506211 Free article.
50 results